We are seeing a big change in personalized medicine with Oncogenome. These tests are changing how we find and treat cancer. They look at hundreds of genes related to cancer at once.
An OncoPanel is a complex test that finds genes causing cancer to grow. It checks many cancer genes at the same time. This helps doctors make better treatment plans for patients with solid tumors.
Key Takeaways
- OncoPanels are advanced NGS tests that analyze hundreds of cancer-related genes.
- These tests detect genetic mutations driving tumor growth.
- OncoPanels provide predictive, prognostic, and diagnostic information.
- They enable clinicians to develop targeted treatment plans for patients with solid tumors.
- OncoPanels are transforming personalized medicine and improving patient outcomes.
The Science Behind OncoPanels in Cancer Diagnostics
OncoPanels look at a wide panel of genes to find out what causes cancer. They help doctors make better treatment plans by knowing the exact genetic makeup of each tumor.
Definition and Core Technology
OncoPanels use next-generation sequencing (NGS) to check many genes linked to cancer. They look at up to 447 genes and find changes in 60 genes. This gives a clear picture of what makes tumors grow.
The technology behind OncoPanels is hybrid capture and massively parallel sequencing. It finds changes in DNA that are specific to tumors. This helps doctors pinpoint the exact genetic changes causing cancer in each patient.
Types of Cancer-Related Genetic Alterations Detected
OncoPanels find many types of genetic changes linked to cancer, including:
- Somatic mutations that make tumors grow and spread.
- Copy number variations that change how genes work and affect cancer.
- Structural variants from changes in chromosomes.
By spotting these changes, OncoPanels help create personalized treatment plans. This is very useful for colorectal next-generation sequencing panels and other specific uses.
The Oncogenome: Complete Analysis Through a Panel of Genes
OncoPanels have changed how we diagnose cancer. They let us check hundreds of genes at once. This is key to finding out what makes tumors grow and finding new treatments.
How OncoPanels Examine Hundreds of Genes Simultaneously
OncoPanels look at many genes related to cancer. For example, the BC Cancer Agency’s OncoPanel checks 447 cancer genes and 191 regions across 60 genes for changes. This gives us a clear picture of what’s happening in a tumor.
They use advanced next-generation sequencing (NGS) to analyze many genes at once. This method is faster and cheaper than testing one gene at a time.
Detecting Genetic Mutations That Drive Tumor Growth
OncoPanels find different kinds of genetic changes. They can spot point mutations, insertions, deletions, and rearrangements. This helps doctors find the right treatments for tumors.
They can also find mutations in CALI genes. This info is very useful for planning treatments.
Examples of Complete Cancer Panels
There are many cancer panels out there, each with its own benefits. For example:
- The OncoPanel at BC Cancer Agency looks at up to 447 genes and checks 60 genes for changes.
- Other panels might focus on certain cancers or cover more genes.
- Comprehensive genomic profiling (CGP) panels, like the CGP panel, give a wide view of the tumor genome. They help find new treatment options.
These panels are changing cancer care. They give detailed genetic info that helps doctors make better treatment plans.
Clinical Applications and Benefits of Oncogenic Testing
Onco-genetic testing has changed how we treat cancer. It uses OncoPanels to give detailed genetic info. This helps doctors choose the best treatments for each patient. Oncogenome research studies cancer-specific genetic changes, helping doctors understand tumor growth, develop targeted therapies, and improve personalized treatment outcomes.
Rapid and Precise Diagnostic Capabilities
Onco genetic testing is quick and accurate. It finds the genetic changes that make tumors grow. This info helps doctors plan treatments that really work.
Studies show that about half of patients have genetic changes that can be treated. This means better care for more people.
OncoPanels are great for rare or hard-to-diagnose cancers. They check hundreds of genes at once. This can find changes that other tests miss.
Personalized Treatment Planning Based on Tumor Profiles
Onco-genetic testing helps tailor treatments to each patient. It looks at the tumor’s genes to find the best treatments. This way, treatments that won’t work are avoided.
This new way of treating cancer is changing patient care. It lets doctors create plans that fit each patient’s cancer perfectly. Patients get better care and better results.
Colorectal Next Generation Sequencing Panel and Other Specialized Applications
OncoPanel testing works for many cancers, like lung and melanoma. There are special panels for cancers like colorectal cancer. These give detailed genetic info for specific cancers.
Key applications of OncoPanels include:
- Identifying actionable mutations to inform targeted therapy decisions
- Providing detailed genomic information for personalized treatment planning
- Detecting genetic alterations associated with specific cancer types
These special uses help doctors make better treatment plans. This leads to better care and outcomes for patients. As precision oncology grows, OncoPanels will play an even bigger role in cancer treatment.
Real-World Impact and Success Rates of CGP Panel Testing
CGP panels have changed how we diagnose and treat cancer. They help us move towards personalized medicine. This is because they can deeply analyze tumor genetics.
Actionable Mutations Identified in Patients
CGP panels can find important mutations in many patients. In Japan, the NCC Oncopanel found such mutations in about half of the patients. This helps doctors choose the best treatments for each patient.
These findings lead to better treatments and new clinical trials. CGP panels make sure patients get the right care for their unique genetic makeup.
Case Studies from Leading Institutions
Genomics BC and other top places are using CGP panels in clinics. Their success stories show how OncoPanel testing works. For example, Genomics BC has seen big improvements in patient care.
These stories show that CGP panels work well for many cancers. They also show the need for teamwork to use these results well.
Integration into Standard Cancer Care
OncoPanels are becoming a key part of cancer care. They are used all over the world for certain cancers. This shows how valuable they are in making treatment choices and improving results.
We expect CGP panels to play a big role in fighting cancer. They will help doctors give more precise and effective care. The future of cancer treatment depends on these genetic analyses.
Conclusion: The Future of OncoPanels in Precision Oncology
OncoPanels are becoming more important in fighting cancer. Next-generation sequencing (NGS) is making it easier to understand cancer genes. Panels like Oncomine Focus Assay and FoundationOne are very good at finding cancer-causing genes.
These panels can spot important changes in genes with great accuracy.
The future of OncoPanels is bright. They help us understand cancer better by looking at many genes at once. We expect OncoPanels to keep helping doctors plan treatments that fit each patient’s cancer.
FAQ
What is an OncoPanel and how does it work?
An OncoPanel is a next-generation sequencing (NGS) test. It looks at many cancer-related genes at once. This helps doctors find the genetic changes that make tumors grow.
It uses NGS technology to check a wide range of genes linked to cancer.
What is the core technology behind OncoPanels?
The core technology uses hybrid capture and massively parallel sequencing. This method finds somatic mutations, copy number variations, and structural variants in tumor DNA.
How do OncoPanels detect genetic mutations that drive tumor growth?
OncoPanels look at hundreds of genes linked to cancer. This helps doctors make treatment plans that fit each patient’s needs.
What are the benefits of using OncoPanels in cancer diagnostics?
OncoPanels offer quick and accurate diagnosis. They help plan treatments based on each tumor’s unique profile. They also find mutations that can be treated with specific therapies.
What is the significance of using OncoPanels in cancer care?
OncoPanels help doctors understand cancer better. They look at many genes and find different mutations. This information helps guide treatment choices.
How have OncoPanels impacted cancer care globally?
OncoPanels have become a key part of cancer care worldwide. They find mutations that can be treated in many patients. This leads to better treatment plans.
What is the role of Genomics BC in OncoPanel testing?
Genomics BC is a leader in OncoPanel testing. They show how this technology works in real-world settings. Their work is very valuable.
What is the future of OncoPanels in precision oncology?
OncoPanels will keep getting better as NGS technology advances. They will play a bigger role in cancer care. This will change how we treat cancer for the better.
Are there specialized OncoPanels for specific cancer types, such as colorectal cancer?
Yes, there are OncoPanels for certain cancers, such as colorectal cancer. These panels give specific insights into the genetic changes in those cancers.
How do OncoPanels contribute to personalized treatment planning?
OncoPanels help doctors find specific mutations in tumors. This lets them create treatment plans that are tailored to each patient. This approach leads to more effective cancer care.
References
- Cheng, D. T., Mitchell, T. N., Zehir, A., Shah, R. H., Benayed, R., Syed, A., … & Berger, M. F. (2015). Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. The Journal of Molecular Diagnostics, 17(3), 251“264.https://www.sciencedirect.com/science/article/pii/S152515781530012X
- Frampton, G. M., Fichtenholtz, A., Otto, G. A., Wang, K., Downing, S. R., He, J., … & Ross, J. S. (2013). Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nature Biotechnology, 31(11), 1023“1031.https://www.nature.com/articles/nbt.2696
- Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., … & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 23(6), 703“713.https://www.nature.com/articles/nm.4333
Departments
Related Videos
Our Doctors
News
